239 related articles for article (PubMed ID: 6138720)
1. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
2. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of relapse in schizophrenia is discontinued too soon. Many colleagues make this mistake!].
Seemann U; Kissling W
MMW Fortschr Med; 2000 Feb; 142(5):34-8. PubMed ID: 10715937
[TBL] [Abstract][Full Text] [Related]
4. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
Gaebel W; Pietzcker A
Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
[No Abstract] [Full Text] [Related]
5. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Odejide OA; Aderounmu AF
J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
[TBL] [Abstract][Full Text] [Related]
6. Dose response of prophylactic antipsychotics.
Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
[TBL] [Abstract][Full Text] [Related]
7. Early, targeted pharmacotherapeutic intervention in schizophrenia.
Carpenter W
J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
[TBL] [Abstract][Full Text] [Related]
8. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
9. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Stanković Z; Britvić D; Vuković O; Ille T
Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
[TBL] [Abstract][Full Text] [Related]
10. Early hospital experience with fluphenazine decanoate.
Small JG; Kellams J
Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
[TBL] [Abstract][Full Text] [Related]
11. [Quotidien prescription: between references and reality].
Verdoux H
Encephale; 2006 Jan; 32 Pt 2():S10-1. PubMed ID: 16800079
[No Abstract] [Full Text] [Related]
12. [Treatment of schizophrenia: what the family doctor should know].
Gruber O; Falkai P
MMW Fortschr Med; 2008 May; 150 Suppl 2():16-9; quiz 20. PubMed ID: 18680837
[No Abstract] [Full Text] [Related]
13. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
14. [Lifelong relapse prevention with antipsychotics in schizophrenia].
Hasan A; Wobrock T
Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
[No Abstract] [Full Text] [Related]
15. [Follow-up treatment of schizophrenic psychoses: advantages and disadvantages of long-term medication].
Steuber H; Kind J; Lohrengel S; Müller P
Arzneimittelforschung; 1978; 28(9):1492-3. PubMed ID: 38806
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for the treatment of schizophrenia.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
[TBL] [Abstract][Full Text] [Related]
17. Maintenance therapy.
Saito H; Saijo T
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S31-4. PubMed ID: 10560895
[TBL] [Abstract][Full Text] [Related]
18. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
19. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
Jayaram G; Coyle J; Tune L
J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
[TBL] [Abstract][Full Text] [Related]
20. [Considerations on the use of long-acting neuroleptics in a mental health center].
Carotti P; Merli R
Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
